Wang Lingke sold $4.6M of LIFE

Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.96 ($38.36–$39.67, $4.61M total) across 3 trades on 2026-09-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang Lingke
Published Sep 18, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIFE
Bearish
medium confidence
Mentioned
$LIFE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFEBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which may be interpreted as a negative sentiment cue, though the pre‑arranged nature tempers the signal.

02

Market read

Primary relevance is to LIFE shareholders; broader market impact is limited.

03

What to watch

Potential upcoming corporate actions or financing needs that prompted the pre‑arranged sale.

Relevance 5/10Novelty 6/10Timing: after market close on 2026-09-18

Background

Form 4 filings disclose insider transactions; a 10b5-1 plan indicates the sale was pre‑scheduled.

Company-level read

Ticker impact

$LIFEBearishMedium confidence
Context

President Wang Lingke sold 118,333 shares for $4.6M via a 10b5-1 plan, reducing his stake to 1.54M shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

A $4.6M sale by a senior officer is material for a small‑cap, but the transaction is pre‑arranged, limiting immediate impact.

Market effects

Minimal; the sale does not affect the broader technology sector.

None; the filing is company‑specific.

Low; limited to investors tracking Ethos Technologies.

Counterpoint

The sale could be purely liquidity‑driven under a 10b5-1 plan, not a bearish signal.

Key entities

  • Ethos Technologies Inc.

    Issuer of the shares sold.

  • Wang Lingke

    President and insider selling shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEHighAI 8/10

Why is Ethos Technologies stock surging today?

Ethos Technologies (LIFE) stock rose 11.4% premarket after Q3 revenue of $235M beat estimates and guidance. Adjusted EBITDA was $35M, also topping forecasts. New policies increased 189% YoY. Citizens raised its price target to $55. Full-year 2026 revenue guidance increased to $838M-$842M.

$LIFEMed

Ethos Technologies Inc (LIFE) (Q3 2026) Earnings Call Highlights: Triple-Digit Revenue

Ethos Technologies (LIFE) reported Q3 2026 revenue of $235M, up 151% YoY, with adjusted EBITDA of $35M, exceeding guidance. Direct and third-party channel revenues grew 112% and 209% YoY, respectively. Contribution margin declined to 28%, and Q4 guidance implies growth deceleration to 102% YoY. Management discussed channel growth, carrier relationships, and margin dynamics during the earnings call.

$LIFEHigh

Ethos Reports Third Quarter Fiscal Year 2026 Financial Results

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Third Quarter Fiscal Year 2026 Financial Results • Q3 Revenue grew 151% year-over-year to $235 million • Q3 Direct Channel Revenue grew 112% year-over-year to $119 million • Q3 Third-Party Channel Revenue grew 209% year-over-year to $116 million Austin,